These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1619922)

  • 21. Augmentation of interleukin-2 immunotherapeutic effects by lymphokine-activated killer cells and allogeneic stimulation in murine tumor cells.
    Eggermont AM; Steller EP; Ottow RT; Matthews W; Sugarbaker PH
    J Natl Cancer Inst; 1987 Nov; 79(5):983-90. PubMed ID: 3500357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.
    Mazumder A; Rosenberg SA
    J Exp Med; 1984 Feb; 159(2):495-507. PubMed ID: 6141211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trafficking of syngeneic murine lymphokine activated killer T cells following intraperitoneal administration in normal and tumor bearing mice.
    Cappuccini F; Lucci JA; Dett CA; Gatanaga M; Ininns EK; Gatanaga T; Yamamoto RS; Manetta A; DiSaia PJ; Granger GA
    Gynecol Oncol; 1992 Aug; 46(2):163-9. PubMed ID: 1500017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice.
    Ettinghausen SE; Puri RK; Rosenberg SA
    J Natl Cancer Inst; 1988 Apr; 80(3):177-88. PubMed ID: 3258039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local conditions in the host influence immunotherapy with interleukin-2 and LAK cells.
    Steller EP; Ottow RT; Eggermont AM; Marquet RL; Sugarbaker PH
    Cancer Detect Prev; 1988; 12(1-6):81-90. PubMed ID: 3263202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model.
    Marincola FM; Da Pozzo LF; Drucker BJ; Holder WD
    Surgery; 1990 Nov; 108(5):919-29. PubMed ID: 2237773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change in peripheral blood lymphocyte count in dogs following adoptive immunotherapy using lymphokine-activated T killer cells combined with palliative tumor resection.
    Mie K; Shimada T; Akiyoshi H; Hayashi A; Ohashi F
    Vet Immunol Immunopathol; 2016 Sep; 177():58-63. PubMed ID: 27436446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.
    Rosenberg SA; Spiess P; Lafreniere R
    Science; 1986 Sep; 233(4770):1318-21. PubMed ID: 3489291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2.
    Ettinghausen SE; Rosenberg SA
    Cancer Res; 1986 Jun; 46(6):2784-92. PubMed ID: 3486038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma.
    Lafreniere R; Rosenberg SA
    J Immunol; 1985 Dec; 135(6):4273-80. PubMed ID: 3877766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive immunotherapy of intracerebral metastases in mice.
    McCutcheon IE; Baranco RA; Katz DA; Saris SC
    J Neurosurg; 1990 Jan; 72(1):102-9. PubMed ID: 2294169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo proliferation of adoptively transferred tumor-infiltrating lymphocytes in mice.
    Wong RA; Alexander RB; Puri RK; Rosenberg SA
    J Immunother (1991); 1991 Apr; 10(2):120-30. PubMed ID: 2043592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion.
    Kuppen PJ; Marinelli A; Camps JA; Pauwels EK; van de Velde CJ; Fleuren GJ; Eggermont AM
    Int J Cancer; 1992 Sep; 52(2):266-70. PubMed ID: 1521913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice.
    Puri RK; Leland P
    Clin Exp Immunol; 1991 Aug; 85(2):317-25. PubMed ID: 1713814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Augmentation of LAK cell-accumulation in tumor tissue and its therapeutic effect after chemotherapy].
    Wakizaka Y; Uchino J
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1441-4. PubMed ID: 1530290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphokine-activated killer cells in autologous bone marrow transplantation. Evidence against inhibition of engraftment in vivo.
    Charak BS; Brynes RK; Chogyoji M; Mazumder A
    Transplantation; 1992 Dec; 54(6):1008-13. PubMed ID: 1465768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICAM-1 increases in vitro adhesion and cytotoxicity in a murine fibrosarcoma.
    Burno DK; Fabian DF; Lefor AT
    J Surg Res; 1996 Feb; 60(2):398-402. PubMed ID: 8598676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfection of a murine fibrosarcoma with intercellular adhesion molecule-1 enhances the response to adoptive immunotherapy.
    Burno DK; Kyprianou N; Sartor WM; Fabian DF; Turner J; Vu T; Patel A; Trimbach C; Lefor AT
    Surgery; 1995 Aug; 118(2):237-43; discussion 243-4. PubMed ID: 7638739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo distribution of murine lymphokine activated killer cells in splenectomized host.
    Chao TY; Chu TM
    Proc Natl Sci Counc Repub China B; 1990 Dec; 14(4):223-7. PubMed ID: 2101449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.
    Belardelli F; Ciolli V; Testa U; Montesoro E; Bulgarini D; Proietti E; Borghi P; Sestili P; Locardi C; Peschle C
    Int J Cancer; 1989 Dec; 44(6):1108-16. PubMed ID: 2606579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.